Status:
RECRUITING
National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
Lead Sponsor:
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Conditions:
Newly-diagnosed APL (de Novo or Therapy-related)
Relapsed APL
Eligibility:
All Genders
18+ years
Brief Summary
The registry aims to document epidemiologic data, treatment and long-term outcome as well as quality of life of patients with APL. Additionally, a biobanking project for further translational studies ...
Detailed Description
* collection of epidemiological data for APL: age distribution, prognostic factors, distribution of subgroups, incidence * documentation of efficacy and safety of the first line and salvage therapy in...
Eligibility Criteria
Inclusion
- newly-diagnosed APL (either de novo or therapy-related), within 12 months of diagnosis
- or relapsed APL, within 12 months of diagnosis of relapse
- confirmed by the presence of the translocation t(15; 17)
- and / or confirmed by the detection of the fusion transcript of PML/RARa
Exclusion
- none
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT02192619
Start Date
July 1 2014
End Date
December 1 2024
Last Update
February 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prof. Dr. U. Platzbecker
Dresden, Germany, 01307